Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA: Methadone vs Buprenorphine/Naloxone for Prescription Opioid Use Disorder
NCT03033732Phase 4Completed
- Start
- Oct 2017
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine, naloxone in opioid use disorder (OUD). Started Oct 2017; status: completed.
02
Drugs
buprenorphinenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03033732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033732.